Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Aug 2026, 00:25
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
BETA has seen a 57.1% gross margin, accelerating from 18.34% in the previous quarter.
This represents a .34% marginal operating leverage, also accelerating from 11.11% previously. In contrast, revenue growth year-over-year (YoY) has been decelerating, moving from 27.5% to 25.3%. The daily volume has been decelerating as well, moving from 50356 shares to 18275 shares. Additionally, the close price has been accelerating, moving from 2295 INR to 2327.7 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 57.1 % | 18.34 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 18.34 % | 11.11 | ▲ |
| REVENUE_GROWTH_YOY | 25.3 % | 27.5 | ▼ |
| PRICE_CHANGE_PERCENT | 1.425 % | — | - |
| DAILY_VOLUME | 18,275 shares | 50,356 | ▼ |
| CLOSE_PRICE | 2,327.7 INR | 2,295 | ▲ |